Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion type Assertion NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_head.
- NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion wasGeneratedBy ECO_0000203 NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_provenance.
- NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion wasDerivedFrom befree-20150227 NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_provenance.
- NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion SIO_000772 17561981 NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_provenance.
- NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion evidence source_evidence_literature NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_provenance.
- NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_assertion description "[These metabolic changes include insulin resistance with type 2 diabetes, acanthosis nigricans, dyslipidaemia predominantly consisting of hypertriglyceridaemia (associated with the onset of pancreatitis) and depressed HDL cholesterol, liver steatosis and hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007225.RAUWJjyCWhdPa74G2g__zHsRqZqVuDyVEZzmkflTOhbXo130_provenance.